Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.

Molecular genetics & genomic medicine - 1 Mar 2018

Eisen Andrea, Blackmore Kristina M, Meschino Wendy S, Muradali Derek, Carroll June C, Majpruz Vicky, Warner Ellen, Rabeneck Linda, Chiarelli Anna M

Abstract excerpt

BACKGROUND: The Ontario Breast Screening Program (OBSP) expanded in July 2011 to screen high-risk women aged 30-69 with annual MRI and mammography. This study evaluated wait time (WT) indicators along the genetic assessment (GA) pathway for women referred to the High Risk OBSP. METHODS: Information was collected for 27,170 women referred to the High Risk OBSP from July 2011 to June 2015 and followed for GA until...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Mass Screening

Share to Ontario

Share to Referral and Consultation

Source

Open in PubMed Open full text

Identifiers

PMID: 29368425
DOI: 10.1002/mgg3.359
PMCID: PMC5902387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.PMID 29368425Read ↗

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity Read ↗

Universal access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia: Evaluating a new collaborative care model.Semantic proximity Read ↗

Perioperative genetic testing and time to surgery in patients with breast cancer.Semantic proximity Read ↗

The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.Semantic proximity Read ↗

Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.Semantic proximity Read ↗

Genetic Counseling Referral Rates in Long-Term Survivors of Triple-Negative Breast Cancer.Semantic proximity Read ↗

Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?Semantic proximity Read ↗

Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.Semantic proximity Read ↗

Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.Semantic proximity Read ↗

Implementation of Risk-Reducing Surgery for HBOC Under Public Insurance in Japan: A Single-Center ExperienceSemantic proximity Read ↗

Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development.Semantic proximity Read ↗

Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.